Home|Best-Bschool-in-india-2018

DSIJ Mindshare

FIIs bought 27,23,098 shares: Ashish Kacholia's portfolio specialty chemical stock in focus as company receives upgrade in credit rating from ICRA FIIs bought 27,23,098 shares: Ashish Kacholia's portfolio specialty chemical stock in focus as company receives upgrade in credit rating from ICRA

FIIs bought 27,23,098 shares: Ashish Kacholia's portfolio specialty chemical stock in focus as company receives upgrade in credit rating from ICRA

The stock is up by 21 per cent from its 52-week low of Rs 281.05 per share and gave multibagger returns of 1,250 per cent returns in 5 years.

Kiran Shroff 0 200 Article rating: 5.0

The stock is up by 21 per cent from its 52-week low of Rs 281.05 per share and gave multibagger returns of 1,250 per cent returns in 5 years.

Read more
Ashish Kacholia’s Portfolio High ROE & High ROCE Chemicals Stock: This small-cap company is into expansion and growth of the business; details inside! Ashish Kacholia’s Portfolio High ROE & High ROCE Chemicals Stock: This small-cap company is into expansion and growth of the business; details inside!

Ashish Kacholia’s Portfolio High ROE & High ROCE Chemicals Stock: This small-cap company is into expansion and growth of the business; details inside!

The stock is down by 20 per cent from its 52-week high of Rs 458 per share while it is up by 45 per cent from its 52-week low of Rs 250.85 per share.

Kiran Shroff 0 8418 Article rating: 3.8

This company is financially strong with a market cap exceeding Rs 4,000 crore and minimal debt.

Read more
Multibagger alert: Do you own this chemical company stock that surged 170 per cent in just one year? Multibagger alert: Do you own this chemical company stock that surged 170 per cent in just one year?

Multibagger alert: Do you own this chemical company stock that surged 170 per cent in just one year?

This multi-bagger stock has a special place in ace investor Ashish Kacholia’s portfolio and soared 113 per cent in just six months. It also generated returns of 170 per cent in one year! 

Sayali Kotwal 0 4394 Article rating: 4.0

Fineotex Chemical has announced that HealthGuard's market-leading, non-heavy metal base anti-microbial treatment, HealthGuard AMIC, has been approved by the US Environmental Protection Agency (EPA). In order to become the sole global marketing & sales channel partner with joint operations out of Malaysia, Fineotex Chemical Limited and HealthGuard® Australia formed a joint venture last year. 

Read more
RSS
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual

View Registration Certificate

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual

View Registration Certificate

Registered Address:
419-A, 4th floor, Arun Chambers,
Tardeo, Next to AC Market, Mumbai - 400 034.
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP
BASL Membership ID: 1346

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Condition | Privacy Statement | WhiteList